Destruction of salivary and lacrimal glands by Th1-polarized reaction in a model of secondary Sjögren's syndrome in lupus-prone female NZB x NZWF 1 mice

Inflammation

Volumn 35, Issue 2, 2012, Pages 638-646

  Hayashi, Toshiharu ^a   Shimoyama, Natsumi ^a   Mizuno, Takuya ^a  

^a YAMAGUCHI UNIVERSITY   (Japan)

Author keywords

Acini; B WF 1 mice; Female; Lupus; Secondary Sj gren's syndrome; Th1; Th2

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; MESSENGER RNA;

AGE DISTRIBUTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CYTOKINE PRODUCTION; DACRYOCYSTITIS; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; IMMUNE RESPONSE; IMMUNOPATHOLOGY; KIDNEY FAILURE; LACRIMAL GLAND; LYMPHOCYTIC INFILTRATION; LYMPHOID CELL; MOUSE; NONHUMAN; SALIVARY GLAND; SECONDARY SJOEGREN SYNDROME; SIALOADENITIS; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; TH1 CELL;

ACINAR CELLS; ANIMALS; CELLS, CULTURED; DACRYOCYSTITIS; FEMALE; IMMUNOGLOBULIN G; INTERFERON-GAMMA; INTERLEUKIN-13; INTERLEUKIN-4; INTERLEUKIN-5; LACRIMAL APPARATUS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICE; MICE, INBRED BALB C; MICE, INBRED NZB; PLASMA CELLS; RENAL INSUFFICIENCY; RNA, MESSENGER; SALIVARY GLANDS; SIALADENITIS; SJOGREN'S SYNDROME; TH1 CELLS; TH1-TH2 BALANCE;

MUS;

EID: 84863783756     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-011-9356-y     Document Type: Article

References (34)

1. Bolch, K.J., W.W. Bluchanan, M.J. Wohl, and J.J. Bunim. 1965. Sjögren's syndrome: clinical, pathological, and serological studies of sixty-two cases. Medicine 44: 187-231.
2. Feltkamp, T.E.W. 1992. Sjögren's syndrome in relation to other autoimmune diseases. The Netherlands Journal of Medicine 40: 105-107.
3. Nishimori, I., Y. Yamamoto, K. Okazaki, M. Morita, M. Onodera, J. Kino, S. Tamura, and Y. Yamamoto. 1994. Identification of autoantibodies to a pancreatic antigen in patients with idiopathic chronic pancreatitis and Sjögren's syndrome. Pancreas 9: 374-381. (Pubitemid 24116725)
4. Mitsias, D.I., E.K. Kapsogeorgou, and H.M. Moutsopoulos. 2006. Sjögren's syndrome: why autoimmune epitheliolitis? Oral Diseases 12: 523-532. (Pubitemid 44624354)
5. Soyfoo, M.S., S. Steinfeld, and C. Delporte. 2007. Usefulness of mouse models to study the pathogenesis of Sjögren's syndrome. Oral Diseases 13: 366-375. (Pubitemid 46934581)
6. Vitali, C., S. Bombardieri, R. Jonsson, H.M. Moutsopoulos, E.L. Alexander, S.E. Carsons, T.E. Daniels, P.C. Fox, R.I. Fox, S.S. Kassan, S.R. Pillemer, N. Talal, and M.H. Weisman. 2002. European Study Group on classification criteria for Sjögren's syndrome. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Annals of the Rheummatic Diseases 61: 554-558. (Pubitemid 34539104)
7. Scofield, R.H. 2009. Genetics of systemic lupus erythematosus and Sjogren's syndrome. Current Opinion in Rheumatology 21: 448-453.
8. Robinson, C.P., J. Cornelius, D.E. Bounous, H. Yamamoto, M.G. Humphreys-Beher, and A.B. Peck. 1998. Characterization of the changing lymphocyte populations and cytokine expression in the exocrine tissues of autoimmune NOD mice. Autoimmunity 27: 29-44. (Pubitemid 28070069)
9. Espinosa, A., V. Dardalhon, S. Brauner, A. Ambrosi, R. Higgs, F.J. Quintana, M.L. Ni Gabhann, O. Winqvist, B. Sundelin, C.A. Jefferies, B. Rozell, V.K. Kuchroo, and M. Wahren-Herlenius. 2009. Loss of the lupus autoantigen Ro52/Trim21 induces tissue inflammation and systemic autoimmunity by disregulating the IL-23-Th17 pathway. The Journal of Experimental Medicine 206: 1661-1671.
10. Nguyen, C.Q., M.H. Hu, Y. Li, C. Stewart, and A.B. Peck. 2008. Salivary gland tissue expression ofinterleukin-23 and interleukin- 17 in Sjogren's syndrome: findings in humans and mice. Arthritis and Rheumatism 58: 734-743. (Pubitemid 351364871)
11. Ohyama, Y., S. Nakamura, G.Matsuzaki, M. Shinohara, A. Hiroki, T. Fujimura, A. Yamada, K. Itoh, and K. Nomoto. 1996. Cytokine messenger RNA expression in the labial salivary glands of patients with Sjögren's syndrome. Arthritis & Rrheumatism 39: 1376-1384. (Pubitemid 26270098)
12. Sun, D., M.R. Emmert-Buck, and P.C. Fox. 1998. Differential cytokine mRNA expression in human labial minor salivary glands in primary Sjögren's syndrome. Autoimmunity 28: 125-137. (Pubitemid 29027563)
13. Fox, R.I., H. Kang, D. Ando, J. Abrams, and E. Pisa. 1994. Cytokine mRNA expression in salivary gland biopsies of Sjögren's syndrome. Journal of Immunology 152: 5532-5539. (Pubitemid 24153003)
14. Matsumoto, I., S. Okada, K. Kuroda, I. Iwamoto, Y. Saito, T. Tokuhisa, K. Nishioka, and T. Sumida. 1999. Single cell analysis of T cells infiltrating labial salivary glands from patients with Sjogren's syndrome. International Journal of Molecular Medicine 4: 519-527.
15. Boumba, D., F.N. Skopouli, and H.M. Moutsopoulos. 1995. Cytokine mRNA expression in the labial salivary gland tissues from patients with primary Sjogren's syndrome. British Journal of Rheumatology 34: 326-333.
16. Jabs, D.A., B. Lee, J.A. Whittum-Hudson, and R.A. Prendergast. 2000. Th1 versus Th2 immune responses in autoimmune lacrimal gland disease in MRL/Mp mice. Investigative Ophthalmology & Visual Science 41: 826-831. (Pubitemid 30158895)
17. Akpek, E.K., D.A. Jabs, H.G. Gerard, R.A. Prendergast, A.P. Hudson, B. Lee, and J.A. Whittum-Hudson. 2004. Chemokines in autoimmune lacrimal gland disease in MRL/MpJ mice. Investigative Ophthalmology & Visual Science 45: 185-190. (Pubitemid 38055686)
18. Cha, S., A.B. Peck, and M.G. Humphereys-Beher. 2002. Progress in understanding autoimmune exocrinopathy using the non-obese diabetic mice: an update. Critical Reviews in Oral Biology and Medicine 13: 4-6.
19. Hayashi, T., H. Hayashi, T. Fujii, C. Adachi, and K. Hasegawa. 2008. Ultrastructure of myoepithelial cells as a target cell insialoadenitis of submandibular glands of lupus-prone female NZB x NZWF1 mice. Virchows Archiv 453: 177-188.
20. + T cell monoclonal antibody exacervates the development of sialoadenitis in submandibular glands in lupusprone female NZB x NZWF1 mice. Journal of Oral Pathology & Medicine 38: 234-240.
21. Greenspan, J.S., G.A. Gutman, I.L. Weissman, and N. Talal. 1974. Thymus-antigen- and immunoglobulin positive lymphocytes in tissue infiltrates of NZB/NZW mice. Clinical Immunology and Immunopathology 3: 16-31.
22. Ihrler, S., S. Blasenbreu-Vogt, A. Sendelhofert, M. Rössle, J.D. Harrison, and U. Löhrs. 2004. Regeneration in chronic sialoadenitis: an analysis of proliferation and apoptosis based on double immunohistochemical labeling. Virchows Archiv 444: 356-361. (Pubitemid 38553641)
23. Miyake, T., M. Inaba, J. Fukui, Y. Ueda, N. Hosaka, Y. Kamiyama, and S. Ikehara. 2008. Prevention of graft-versus-host disease by intrabone marrow injection of donor T cells: involvement of bone marrow stromal cells. Clinical and Experimental Immunology 152: 153-162. (Pubitemid 351347565)
24. Menon, K., Y. Wu, J. Haas, S.K. Sahu, B. Yang, and A. Zaheer. 2007. Diminished degradation of myelin basic protein by antisulfatide antibody and interferon-gamma in myelin from glia maturation factor-deficient mice. Neuroscience Research 58: 156-163. (Pubitemid 46843326)
25. Wen, Y., J. Gu, G.E. Vandenhoff, X. Liu, and J.L. Nadler. 2008. Role of 12/15-lipoxygenase in the expression of MCP-1 in mouse macrophages. American Journal of Physiology. Heart and Circulatory Physiology 294: H1933-H1938. (Pubitemid 351490623)
26. Kapsogeorgou, E.K., I.D. Dimitriou, R.F. Abu-Helu, H.M. Moutsopoulos, and M.N. Manoussakis. 2001. Activation of epithelial and myoepithelial cells in the salivary glands of patients with Sjögren's syndrome:high expression of intercellular adhesion molecule-1(ICAM.1) in biopsy specimens and cultured cells. Clinical and Experimental Immunology 124: 126-133. (Pubitemid 32476942)
27. Mosmann, T.R., and R.L. Coffman. 1989. TH1 and TH2 cells; different patterns of lymphokine secretion lead to different functional properties. Annual Reviews of Immunology 7: 145-173. (Pubitemid 19138011)
28. Kolkowski, E.C., P. Reth, F. Pelusa, J. Bosch, R. Pujol-Borrell, J. Coll, and D. Jaraquemada. 1999. Th1 predominance and perforin expression in minor salivary glands from patients with primary Sjögren's syndrome. Journal of Autoimmunity 13: 155-162. (Pubitemid 29367020)
29. Hayashi, T., K. Hasegawa, Y. Sasaki, T. Mori, C. Adachi, and K. Maeda. 2007. Systemic administration of interleukin-4 expressing plasmid DNA delays the development of glomerulonephritis and prolongs survival in lupus-prone female NZB x NZWF1 mice. Nephrology, Dialysis, Transplantation 22: 3 131-3138.
30. Mitsias, D.I., A.G. Tzioufas, C. Veiopoulou, E. Zintzaras, I.K. Tassios, O. Kogopoulou, H.M. Moutsopoulos, and G. Thyphronitis. 2002. The Th1/Th2 cytokine balance changes with the progress of the immunopathological lesion of Sjögren's syndrome. Clinical and Experimental Immunology 128: 562-568. (Pubitemid 34639321)
31. Ogawa, N., L. Ping, L. Zhenjun, Y. Takada, and S. Sugai. 2002. Involvement of the interferon-γ-inducible 10-kd protein (CXCL10) and monokine induced by interferon-γ (CXCL9), in the salivary gland lesions of patients with Sjögren's syndrome. Arthritis & Rrheumatism 46: 2730-2741. (Pubitemid 36118938)
32. Ogawa, N., K. Shimoyama, and T. Kawakami. 2004. Molecular mechanisms of salivary gland destruction in patients with Sjögren's syndrome. Japanese Journal of Clinical Immunology 28: 10-20.
33. Jabs, D.A., and R.A. Prendergast. 1988. Murine models of Sjögren's syndrome. Immunohistologic analysis of different strains. Investigative Ophthalmology & Visual Science 29: 1437-1443.
34. Hayashi, T. 2010. Therapeutic strategies for SLE involving cytokines:mechanism-oriented therapy especially IFN-γ targeting gene therapy. Journal of Biomedicine and Biotechnology. doi:10.1155/2010/461641. Article ID 461641, 19 pages.